Eagle Bay Advisors LLC Coherus Bio Sciences, Inc. Transaction History
Eagle Bay Advisors LLC
- $157 Million
- Q1 2024
A detailed history of Eagle Bay Advisors LLC transactions in Coherus Bio Sciences, Inc. stock. As of the latest transaction made, Eagle Bay Advisors LLC holds 30 shares of CHRS stock, worth $49. This represents 0.0% of its overall portfolio holdings.
Number of Shares
30
Previous 69
56.52%
Holding current value
$49
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding CHRS
# of Institutions
147Shares Held
83MCall Options Held
184KPut Options Held
255K-
Black Rock Inc. New York, NY11.2MShares$18.4 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY10.4MShares$17.1 Million0.85% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$16.5 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U07.38MShares$12.1 Million0.1% of portfolio
-
Kohlberg Kravis Roberts & Co. L.P. New York, NY3.04MShares$4.98 Million0.31% of portfolio
About Coherus BioSciences, Inc.
- Ticker CHRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,724,600
- Market Cap $127M
- Description
- Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...